Ovarian cancer after successful ovulation induction: A case report

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 41, Issue 1, 1996, Pages 52-54

  Hull, Magdalen E ^a   Kriner, Mary ^b   Schneider, Elizabeth ^b   Maiman, Mitchell ^c  

^a STONY BROOK UNIVERSITY   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

ovarian neoplasms; ovulation induction

Indexed keywords

CLOMIFENE CITRATE; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN;

ADULT; ARTICLE; CANCER RISK; CASE REPORT; FEMALE; FEMALE INFERTILITY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARIECTOMY; OVARY CANCER; OVULATION INDUCTION; PAPILLARY CARCINOMA; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; CARCINOMA; CLOMIPHENE; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; OVARIAN NEOPLASMS; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME;

EID: 0030043840     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Weiss N, Homochuk T, Young J: Incidence of the histologic types of ovarian cancer: The U.S. Third National Cancer Survey, 1966-1971. Gynecol Oncol 1977;5:161-167
2. Perez RP, Godwin AK, Hamilton TC, et al: Ovarian cancer biology. Semin Oncol 1991;18:186-204
3. Lin RS, Kessler II: An epidemiologic perspective on ovarian cancer. In Gynecology and Obstetrics. Edited by JJR Lurian, JJ Sciarra. Philadelphia, JB Lippincott, 1992, pp 1-17
4. Whittemore AS, Harris R, Itnyre J, et al: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies: I. Methods. Am J Epidemiol 1992;136: 1175-1183
5. Whittemore AS, Harris R, Itnyre J, et al: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies: II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992;136:1184-1203
6. Whittemore AS, Harris R, Itnyre J, et al: Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies: III. Epithelial tumors of low malignant potential in white women. Am J Epidemiol 1992;136:1204-1211
7. Whittemore AS, Harris R, Itnyre J, et al: Characteristics relating to ovarian cancer risk: Collaborative analysis of epithelial ovarian cancer. Am J Epidemiol 1992;136:1212-1220
8. Bamford PN, Steele SJ: Uterine and ovarian carcinoma in a patient receiving gonadotropin therapy: Case report. Br J Obstet Gynaecol 1982;89:962-964
9. Atlas M, Menczer J: Massive hyperstimulation and borderline carcinoma of the ovary. Acta Obstet Gynecol Scand 1982;61:261-263
10. Goldberg GL, Runowicz CD: Ovarian carcinoma of low malignant potential, infertility and induction of ovulation: Is there a link? Am J Obstet Gynecol 1991;166:853-854
11. Ron E, Lunenfeld B, Menczer J, et al: Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780
12. Negri E, Franceschi S, La Vecchia C, et al: Incomplete pregnancies and ovarian cancer risk. Gynecol Oncol 1992;47:234-238
13. Cramer D, Hutchinson GB, Welch W, et al: Determinants of ovarian cancer risk: II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-721
14. Emons G, Ortmann O, Pahwa GS, et al: Intracellular actions of gonadotropic and peptide hormones and the therapeutic value of Gn-RH agonists in ovarian cancer. Acta Obstet Gynecol Scand (suppl) 1992;155:31-38
15. Wimalasena J, Dostal R, Meehan D: Gonadotropins, estradiol, and growth factors regulate epithelial ovarian cancer cell growth. Gynecol Oncol 1992;46:345-350
16. Fishel S, Jackson P: Follicular stimulation for high tech pregnancies: Are we playing it safe? Br Med J 1989;299:309-311